miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways

Patients with inflammatory bowel disease are at increased risk for colitis-associated colorectal cancer (CAC). Therefore, controlling intestinal inflammation is a key therapeutic strategy for CAC. MicroRNAs (miRNAs or miRs) are a family of small noncoding RNAs that have the capacity to regulate fund...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Fu, Xianghui, Xie, Jiansheng, Pan, Hongming, Han, Weidong, Huang, Wendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985669/
https://www.ncbi.nlm.nih.gov/pubmed/33815939
http://dx.doi.org/10.1016/j.omtn.2021.02.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985669/
https://www.ncbi.nlm.nih.gov/pubmed/33815939
http://dx.doi.org/10.1016/j.omtn.2021.02.029

Ejemplares similares